Synergistic Effects of Celecoxib and Bupropion in a Model of Chronic Inflammation-Related Depression in Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Maciel, Izaque S ^a   Silva, Rodrigo B M ^a   Morrone, Fernanda B ^a   Calixto, João B ^b   Campos, Maria M ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CELECOXIB; CYCLOOXYGENASE 2; DEXAMETHASONE; DIPYRONE; FLUOXETINE; IMIPRAMINE; INDOMETACIN; INTERLEUKIN 1BETA; PREGABALIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG POTENTIATION; FORCED SWIMMING TEST; MALE; MOUSE; NONHUMAN; PAW EDEMA; PROTEIN EXPRESSION;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUPROPION; CEREBRAL CORTEX; CYCLOOXYGENASE 2; DEPRESSION; DIPYRONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EDEMA; FREUND'S ADJUVANT; GAMMA-AMINOBUTYRIC ACID; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MICE; NOCICEPTION; PYRAZOLES; SULFONAMIDES;

EID: 84884681028     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077227     Document Type: Article

References (70)

1. Wittchen HU, Knäuper B, Kessler RC, (1994) Lifetime risk of depression. Br J Psychiatry Suppl: pp. 16-22. PubMed: 7873133.
2. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, et al. (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105. doi:10.1001/jama.289.23.3095. PubMed: 12813115.
3. Murray CJ, Lopez AD, (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504. doi:10.1016/S0140-6736(96)07492-2. PubMed: 9167458.
4. Lohoff FW, (2010) Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 12: 539-546. doi:10.1007/s11920-010-0150-6. PubMed: 20848240.
5. Wichers M, Geschwind N, Jacobs N, Kenis G, Peeters F, et al. (2009) Transition from stress sensitivity to a depressive state: longitudinal twin study. Br J Psychiatry 195: 498-503. doi:10.1192/bjp.bp.108.056853. PubMed: 19949197.
6. Dantzer R, Kelley KW, (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21: 153-160. doi:10.1016/j.bbi.2006.09.006. PubMed: 17088043.
7. Raison CL, Capuron L, Miller AH, (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27: 24-31. doi:10.1016/j.it.2005.11.006. PubMed: 16316783.
8. Capuron L, Miller AH, (2004) Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56: 819-824. doi:10.1016/j.biopsych.2004.02.009. PubMed: 15576057.
9. Murphy LB, Sacks JJ, Brady TJ, Hootman JM, Chapman DP, (2012) Anxiety and depression among US adults with arthritis: Prevalence and correlates. Arthritis Care Res (Hoboken) 64: 968-976. PubMed: 22550055.
10. Schmidt HD, Shelton RC, Duman RS, (2011) Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology. Neuropsychopharmacology 36: 2375-2394. PubMed: 21814182.
11. Maes M, Smith R, Scharpe S, (1995) The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20: 111-116. doi:10.1016/0306-4530(94)00066-J. PubMed: 7899532.
12. Smith RS, (1991) The macrophage theory of depression. Med Hypotheses 35: 298-306. doi:10.1016/0306-9877(91)90272-Z. PubMed: 1943879.
13. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW, (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56. doi:10.1038/nrn2297. PubMed: 18073775.
14. O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, et al. (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29: 4200-4209. doi:10.1523/JNEUROSCI.5032-08.2009. PubMed: 19339614.
15. Viana AF, Maciel IS, Dornelles FN, Figueiredo CP, Siqueira JM, et al. (2010) Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. J Neuroinflammation 7: 98. doi:10.1186/1742-2094-7-98. PubMed: 21194425.
16. O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, et al. (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511-522. doi:10.1038/sj.mp.4002148. PubMed: 18195714.
17. Kim H, Chen L, Lim G, Sung B, Wang S, et al. (2012) Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 122: 2940-2954. PubMed: 22751107.
18. Chen CY, Tzeng NS, Chen YC, (2010) Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction. Gen Hosp Psychiatry 32: e647-e649. PubMed: 21112464.
19. Johansson D, Falk A, Marcus MM, Svensson TH, (2012) Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat. Prog Neuropsychopharmacol Biol Psychiatry 39: 143-148. doi:10.1016/j.pnpbp.2012.06.003. PubMed: 22691715.
20. Liu D, Wang Z, Liu S, Wang F, Zhao S, et al. (2011) Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Neuropharmacology 61: 592-599. doi:10.1016/j.neuropharm.2011.04.033. PubMed: 21575647.
21. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, et al. (2012) A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 26: 469-479. doi:10.1016/j.bbi.2011.12.011. PubMed: 22251606.
22. Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, et al. (2002) The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 63: 963-971. doi:10.4088/JCP.v63n1102. PubMed: 12444808.
23. Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, et al. (2009) What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 116: 4-11. doi:10.1016/j.jad.2008.10.014. PubMed: 19007996.
24. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, et al. (2006) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31: 739-750. doi:10.1038/sj.npp.1300858. PubMed: 16123756.
25. Zimmermann M, (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110. doi:10.1016/0304-3959(83)90201-4. PubMed: 6877845.
26. Steru L, Chermat R, Thierry B, Simon P, (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370. doi:10.1007/BF00428203. PubMed: 3923523.
27. Caldarone BJ, Karthigeyan K, Harrist A, Hunsberger JG, Wittmack E, et al. (2003) Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice. Psychopharmacology (Berl) 170: 94-101. doi:10.1007/s00213-003-1518-7. PubMed: 12879206.
28. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL, (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63. doi:10.1016/0165-0270(94)90144-9. PubMed: 7990513.
29. Souza AH, Ferreira J, Cordeiro Mdo N, Vieira LB, De Castro CJ, et al. (2008) Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom. Pain 140: 115-126. doi:10.1016/j.pain.2008.07.014. PubMed: 18774645.
30. Dixon WJ, (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20: 441-462. doi:10.1146/annurev.pa.20.040180.002301. PubMed: 7387124.
31. dos Santos DA, Fukui Mde J, Dhammika Nanayakkara NP, Khan SI, Sousa JP, et al. (2010) Anti-inflammatory and antinociceptive effects of Baccharis dracunculifolia DC (Asteraceae) in different experimental models. J Ethnopharmacol 127: 543-550. doi:10.1016/j.jep.2009.09.061. PubMed: 19808087.
32. Soncini R, de Souza DF, Neves AP, Braga DS, Andrade CA, et al. (2012) Dipyrone attenuates acute sickness response to lipopolysaccharide in mice. Neurosci Lett 516: 114-118. doi:10.1016/j.neulet.2012.03.070. PubMed: 22490882.
33. Yamamoto H, Shimoshige Y, Yamaji T, Murai N, Aoki T, et al. (2009) Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats. Neuropharmacology 57: 403-408. doi:10.1016/j.neuropharm.2009.06.037. PubMed: 19591853.
34. Inoue N, Ito S, Tajima K, Nogawa M, Takahashi Y, et al. (2009) Etodolac attenuates mechanical allodynia in a mouse model of neuropathic pain. J Pharmacol Sci 109: 600-605. doi:10.1254/jphs.08287FP. PubMed: 19346674.
35. Tanti A, Belzung C, (2010) Open questions in current models of antidepressant action. Br J Pharmacol 159: 1187-1200. doi:10.1111/j.1476-5381.2009.00585.x. PubMed: 20132212.
36. Farooq RK, Isingrini E, Tanti A, Le Guisquet AM, Arlicot N, et al. (2012) Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? Behav Brain Res 231: 130-137. doi:10.1016/j.bbr.2012.03.020. PubMed: 22465167.
37. Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR, (2010) Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol 159: 122-128. doi:10.1111/j.1476-5381.2009.00521.x. PubMed: 20002102.
38. Pereira PJ, Lazarotto LF, Leal PC, Lopes TG, Morrone FB, et al. (2011) Inhibition of phosphatidylinositol-3 kinase gamma reduces pruriceptive, inflammatory, and nociceptive responses induced by trypsin in mice. Pain 152: 2861-2869. doi:10.1016/j.pain.2011.09.016. PubMed: 22001656.
39. Fu X, Zunich SM, O'Connor JC, Kavelaars A, Dantzer R, et al. (2010) Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation 7: 43. doi:10.1186/1742-2094-7-43. PubMed: 20678226.
40. Moreau M, André C, O'Connor JC, Dumich SA, Woods JA, et al. (2008) Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav Immun 22: 1087-1095. doi:10.1016/j.bbi.2008.04.001. PubMed: 18479887.
41. Müller N, Myint AM, Schwarz MJ, (2011) Inflammatory biomarkers and depression. Neurotox Res 19: 308-318. doi:10.1007/s12640-010-9210-2. PubMed: 20658274.
42. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, et al. (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15: 393-403. doi:10.1038/mp.2009.116. PubMed: 19918244.
43. Jesse CR, Wilhelm EA, Nogueira CW, (2010) Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion. Psychopharmacology (Berl) 212: 513-522. doi:10.1007/s00213-010-1977-6. PubMed: 20689938.
44. Barichello T, Milioli G, Generoso JS, Cipriano AL, Costa CS, et al. (2012) Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats. J Neural Transm 119: 653-660. doi:10.1007/s00702-011-0749-8. PubMed: 22160551.
45. Ma XC, Jiang D, Jiang WH, Wang F, Jia M, et al. (2011) Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLOS ONE 6: e20955. doi:10.1371/journal.pone.0020955. PubMed: 21698062.
46. Matsuzawa-Yanagida K, Narita M, Nakajima M, Kuzumaki N, Niikura K, et al. (2008) Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology 33: 1952-1965. doi:10.1038/sj.npp.1301590. PubMed: 17957217.
47. Carroll JC, Iba M, Bangasser DA, Valentino RJ, James MJ, et al. (2011) Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy. J Neurosci 31: 14436-14449. doi:10.1523/JNEUROSCI.3836-11.2011. PubMed: 21976528.
48. Blatteau JE, Barre S, Pascual A, Castagna O, Abraini JH, et al. (2012) Protective effects of fluoxetine on decompression sickness in mice. PLOS ONE 7: e49069. doi:10.1371/journal.pone.0049069. PubMed: 23145072.
49. Ohgi Y, Futamura T, Kikuchi T, Hashimoto K, (2013) Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav 103: 853-859. doi:10.1016/j.pbb.2012.12.003. PubMed: 23262300.
50. Recla JM, (2010) New and emerging therapeutic agents for the treatment of fibromyalgia: an update. J Pain Res 3: 89-103. PubMed: 21197313.
51. Bernardi A, Zilberstein AC, Jäger E, Campos MM, Morrone FB, et al. (2009) Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats. Br J Pharmacol 158: 1104-1111. doi:10.1111/j.1476-5381.2009.00244.x. PubMed: 19422380.
52. Vartanian MG, Radulovic LL, Kinsora JJ, Serpa KA, Vergnes M, et al. (2006) Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res 68: 189-205. doi:10.1016/j.eplepsyres.2005.11.001. PubMed: 16337109.
53. Yokoyama T, Maeda Y, Audette KM, Sluka KA, (2007) Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. J Pain 8: 422-429. doi:10.1016/j.jpain.2006.11.007. PubMed: 17293165.
54. Park HJ, Joo HS, Chang HW, Lee JY, Hong SH, et al. (2010) Attenuation of neuropathy-induced allodynia following intraplantar injection of pregabalin. Can J Anaesth 57: 664-671. doi:10.1007/s12630-010-9318-0. PubMed: 20440664.
55. Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB, (2006) A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 6: 903-907. doi:10.1016/j.intimp.2005.12.007. PubMed: 16644475.
56. Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, et al. (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26: 607-611. doi:10.1002/da.20589. PubMed: 19496103.
57. Guo JY, Li CY, Ruan YP, Sun M, Qi XL, et al. (2009) Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol 612: 54-60. doi:10.1016/j.ejphar.2009.03.076. PubMed: 19356723.
58. Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S, (2012) Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord 141: 308-314. doi:10.1016/j.jad.2012.03.033. PubMed: 22516310.
59. Thase ME, Howland RH, Friedman ES, (1998) Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry 59 (Suppl 5) ():: 12-15; discussion: 9635543.
60. Bay-Richter C, Janelidze S, Hallberg L, Brundin L, (2011) Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behav Brain Res 222: 193-199. doi:10.1016/j.bbr.2011.03.060. PubMed: 21466824.
61. Felger JC, Miller AH, (2012) Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol 33: 315-327. doi:10.1016/j.yfrne.2012.09.003. PubMed: 23000204.
62. Kim EJ, Lee JE, Kwon KJ, Lee SH, Moon CH, et al. (2001) Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures. Brain Res 908: 1-9. doi:10.1016/S0006-8993(01)02432-5. PubMed: 11457426.
63. Nogawa S, Zhang F, Ross ME, Iadecola C, (1997) Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17: 2746-2755. PubMed: 9092596.
64. Cassano P, Hidalgo A, Burgos V, Adris S, Argibay P, (2006) Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression). Pharmacogenomics J 6: 381-387. doi:10.1038/sj.tpj.6500385. PubMed: 16568149.
65. Gałecki P, Gałecka E, Maes M, Chamielec M, Orzechowska A, et al. (2012) The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord 138: 360-366. doi:10.1016/j.jad.2012.01.016. PubMed: 22331023.
66. Yu H, Chen ZY, (2011) The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 32: 3-11. doi:10.1038/aps.2010.184. PubMed: 21131999.
67. Castrén E, Rantamäki T, (2010) The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol 70: 289-297. doi:10.1002/dneu.20758. PubMed: 20186711.
68. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM, (2008) Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63: 642-649. doi:10.1016/j.biopsych.2007.09.019. PubMed: 17981266.
69. Schmidt LS, Miller AD, Lester DB, Bay-Richter C, Schülein C, et al. (2010) Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice. Psychopharmacology (Berl) 207: 547-558. doi:10.1007/s00213-009-1685-2. PubMed: 19820917.
70. Duman RS, Monteggia LM, (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127. doi:10.1016/j.biopsych.2006.02.013. PubMed: 16631126.